BG101647A - Low molecular weight bicyclic thrombin inhibitors - Google Patents

Low molecular weight bicyclic thrombin inhibitors

Info

Publication number
BG101647A
BG101647A BG101647A BG10164797A BG101647A BG 101647 A BG101647 A BG 101647A BG 101647 A BG101647 A BG 101647A BG 10164797 A BG10164797 A BG 10164797A BG 101647 A BG101647 A BG 101647A
Authority
BG
Bulgaria
Prior art keywords
molecular weight
low molecular
treatment
thrombin inhibitors
relates
Prior art date
Application number
BG101647A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Dimaio
Arshad Siddiqui
John Gillard
Yves St-Denis
Micheline Tarazi
Patrice Preville
Sophie Levesque
Benoit Bachand
Jeremy Edmonds
Annette Doherty
Original Assignee
Biochem Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426038.7A external-priority patent/GB9426038D0/en
Priority claimed from GBGB9510267.9A external-priority patent/GB9510267D0/en
Priority claimed from GBGB9510265.3A external-priority patent/GB9510265D0/en
Priority claimed from GBGB9510266.1A external-priority patent/GB9510266D0/en
Application filed by Biochem Pharma Inc. filed Critical Biochem Pharma Inc.
Publication of BG101647A publication Critical patent/BG101647A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
BG101647A 1994-12-22 1997-06-20 Low molecular weight bicyclic thrombin inhibitors BG101647A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9426038.7A GB9426038D0 (en) 1994-12-22 1994-12-22 Low molecular weight bicyclic thrombin inhibitors
GBGB9503136.5A GB9503136D0 (en) 1994-12-22 1995-02-17 Low molecular weight bicyclic thrombin inhibitors
GBGB9510267.9A GB9510267D0 (en) 1995-05-22 1995-05-22 Low molecular weight thiobicyclic thrombin inhibitors
GBGB9510265.3A GB9510265D0 (en) 1995-05-22 1995-05-22 Low molecular weight diaminobicyclic thrombin inhibitors
GBGB9510266.1A GB9510266D0 (en) 1995-05-22 1995-05-22 Low molecular weight bicyclic thrombin inhibitors
PCT/CA1995/000708 WO1996019483A1 (fr) 1994-12-22 1995-12-21 Inhibiteurs de la thrombine bicyclique a faible poids moleculaire

Publications (1)

Publication Number Publication Date
BG101647A true BG101647A (en) 1998-03-31

Family

ID=27517273

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101647A BG101647A (en) 1994-12-22 1997-06-20 Low molecular weight bicyclic thrombin inhibitors

Country Status (22)

Country Link
EP (1) EP0802916A1 (fr)
JP (1) JPH11508535A (fr)
CN (1) CN1175259A (fr)
AP (1) AP9701004A0 (fr)
AU (2) AU4250596A (fr)
BG (1) BG101647A (fr)
CA (1) CA2208772A1 (fr)
CZ (1) CZ189997A3 (fr)
EE (1) EE9700113A (fr)
FI (1) FI972466A (fr)
HU (1) HUT77651A (fr)
IL (1) IL116503A0 (fr)
IS (1) IS4504A (fr)
LV (1) LV12019B (fr)
MD (1) MD970253A (fr)
MX (1) MX9704718A (fr)
NO (1) NO972892L (fr)
NZ (1) NZ297360A (fr)
OA (1) OA10493A (fr)
PL (1) PL320965A1 (fr)
SK (1) SK83897A3 (fr)
WO (1) WO1996019483A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245764B1 (en) 1995-03-24 2001-06-12 Molecumetics Ltd. β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6699869B1 (en) 1995-03-24 2004-03-02 Myriad Genetics Inc. β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6020331A (en) * 1995-03-24 2000-02-01 Molecumetics, Ltd. β-sheet mimetics and use thereof as protease inhibitors
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
IL119466A (en) * 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
TR199801569T2 (xx) * 1996-02-13 1998-10-21 Akzo Nobel N.V. Serin proteaz inhibit�rleri.
TW442452B (en) * 1996-03-01 2001-06-23 Akzo Nobel Nv Serine protease inhibitors having an alkynylamino side chain
IL120311A (en) * 1996-03-01 2001-10-31 Akzo Nobel Nv Serine protease inhibitors and pharmaceuticals containing them
US6124291A (en) * 1996-06-18 2000-09-26 Warner-Lambert Company Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
ATE320811T1 (de) * 1996-08-05 2006-04-15 Myriad Genetics Inc Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
US6117896A (en) 1997-02-10 2000-09-12 Molecumetics Ltd. Methods for regulating transcription factors
EP1661566A3 (fr) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Utilisation de mimétiques de feuillets beta comme inhibiteurs de protéase et de kinase ou comme inhibiteurs de facteurs de transcription
WO1998009987A1 (fr) * 1996-09-06 1998-03-12 Biochem Pharma, Inc. Inhibiteurs lactame de la thrombine
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
AU5526098A (en) * 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
EP0975659A1 (fr) * 1997-04-14 2000-02-02 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
EP0977773A1 (fr) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
CA2301614A1 (fr) * 1997-09-23 1999-04-01 Merck & Co., Inc. Inhibiteurs de thrombine
WO1999041276A1 (fr) * 1998-02-12 1999-08-19 Molecumetics Ltd. Imitateurs de beta feuillets et procedes lies a leur utilisation
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
AU2381600A (en) 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
AU3208500A (en) 1999-01-27 2000-08-18 Ortho-Mcneil Pharmaceutical, Inc. Peptidyl heterocyclic ketones useful as tryptase inhibitors
FR2795072B1 (fr) * 1999-06-15 2001-07-27 Adir Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE343562T1 (de) * 2000-03-23 2006-11-15 Elan Pharm Inc Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
WO2002002519A2 (fr) * 2000-06-29 2002-01-10 Bristol-Myers Squibb Pharma Company Inhibiteurs de la thrombine ou du facteur xa
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
WO2003068237A1 (fr) 2002-02-14 2003-08-21 Myriad Genetics, Inc. Mimetiques de feuillet $g(b) ; compositions et methodes connexes
US7629318B2 (en) 2002-03-22 2009-12-08 Gpc Biotech Ag Immunosuppressant compounds, methods and uses related thereto
CN111349053A (zh) 2014-10-06 2020-06-30 库特克希米公司 赖氨酸牙龈卟啉菌蛋白酶的抑制剂
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
WO2017083433A1 (fr) 2015-11-09 2017-05-18 Cortexyme, Inc. Inhibiteurs d'arginine gingipaïne
AU2017326466B2 (en) 2016-09-16 2021-11-11 Lighthouse Pharmaceuticals, Inc. Ketone inhibitors of lysine gingipain
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
EP3746444B1 (fr) 2018-01-31 2023-09-27 Janssen Sciences Ireland Unlimited Company Pyrazolopyrimidines substituées de cycloalkyle présentant une activité contre le virus respiratoire syncytial
ES2957316T3 (es) 2018-04-23 2024-01-17 Janssen Sciences Ireland Unlimited Co Compuestos heteroaromáticos que tienen actividad contra VSR

Also Published As

Publication number Publication date
CZ189997A3 (cs) 1998-09-16
HUT77651A (hu) 1998-07-28
FI972466A0 (fi) 1997-06-11
LV12019A (lv) 1998-04-20
NO972892L (no) 1997-08-20
AU715378B2 (en) 2000-02-03
CN1175259A (zh) 1998-03-04
LV12019B (en) 1998-07-20
NO972892D0 (no) 1997-06-20
WO1996019483A1 (fr) 1996-06-27
OA10493A (en) 2002-04-10
EE9700113A (et) 1997-12-15
SK83897A3 (en) 1998-05-06
MX9704718A (es) 1998-06-28
AU4250596A (en) 1996-07-10
AU4062895A (en) 1996-07-04
MD970253A (ro) 1999-05-31
JPH11508535A (ja) 1999-07-27
CA2208772A1 (fr) 1996-06-27
EP0802916A1 (fr) 1997-10-29
IS4504A (is) 1997-06-11
AP9701004A0 (en) 1997-07-31
PL320965A1 (en) 1997-11-24
IL116503A0 (en) 1996-03-31
NZ297360A (en) 2000-03-27
FI972466A (fi) 1997-08-19

Similar Documents

Publication Publication Date Title
BG101647A (en) Low molecular weight bicyclic thrombin inhibitors
NL970045I1 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
BG103232A (en) Heterocyclic esters and amides
NO177785C (no) Analogifremgangsmåter for fremstilling av terapeutisk aktive alkoksy-4(1H)-pyridonderivater
DE68919361T2 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
AP9100310A0 (en) Tnf inhibitors
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
CA2208673A1 (fr) Composition pour inhiber l'hyperplasie de l'intima a l'aide d'antagonistes du facteur de croissance d'origine plaquettaire et de l'heparine
ES2086436T3 (es) Nuevos eteres y tioeteres de piperidilo inhibidores de la biosintesis de colesterol.
DK302288A (da) Vaevsplasminogenaktivator med modificeret kringledomaene
TW369541B (en) Thrombin inhibitors
AU579413B2 (en) 4-Alkoxy-pyrido (2,3-d) pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
AUPP345098A0 (en) Novel anti-fibrinolytic agents
GR3023211T3 (en) Use of staphylokinase for the preparation of a pharmaceutical composition for treating arterial thrombosis
MX9704594A (es) Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina.
FR2633168B1 (fr) Element de structure, notamment pour mobilier du genre table, bureau ou analogue
AU6205390A (en) Pharmaceutical compositions
HU904162D0 (en) Medical compositions for the releasing of coronary convulsion by potentionating nitratic effect and for the releasing of fibrin
IT1206319B (it) Dispositivo per lo scorrimento e l'ancoraggio di cassetti, cestelli corpi estraibili in genere, da mobili ed altro.
IT8719950A0 (it) Struttura componibile per la realizzazione di mobili, scaffali, tavoli, carrelli e simili.
IT215856Z2 (it) Ripiano per la costruzione di tavoli scaffalature e simili
IT1178145B (it) Struttura reticolare spaziale componibile per scaffalature, mobili, panchine e simili
AU3840385A (en) Tricyclic nitrogen-containing diones